EVOPEDIA

← all systems · see it in The System

Pancreas

The pancreas is a vertebrate organ with two jobs in one gland. Its exocrine part (about 99%: acinar cells in clusters round a branching duct tree) makes digestive enzymes, secreted as inactive zymogens, and its duct cells add a bicarbonate-rich fluid; 1.5-3 litres of this pancreatic juice a day pour into the duodenum, where the enzymes are switched on to break down proteins, fats and starch and the bicarbonate neutralises stomach acid. Its endocrine part (about 1%: around a million islets of Langerhans) reads the blood: beta cells secrete insulin when glucose rises, alpha cells secrete glucagon when it falls, delta cells secrete somatostatin, PP and epsilon cells pancreatic polypeptide and ghrelin. With the liver it holds blood sugar within a narrow range, steered also by gut hormones (incretins, secretin, cholecystokinin) and by vagal and sympathetic nerves. Its diseases include pancreatitis (the enzymes digesting the gland), diabetes (beta cells destroyed or failing) and pancreatic cancer.

Properties published scienceour proposal

Sourced fields, and our own readings.

born atfor one pancreas: 27-29 days post conception; for the kind: with the vertebrates (no date in the sources read)
born precisiondays (one pancreas); not dated (the kind)
boundaryInside: the gland within its thin capsule, lying behind the stomach from the duodenal curve to the spleen (head, neck, body, tail): the acini of acinar cells, the centroacinar and duct cells and the duct tree down to the main and accessory pancreatic ducts, about a million islets (alpha, beta, delta, PP and epsilon cells with their own fenestrated capillaries), the stroma (fibroblasts, stellate cells), resident immune cells, and the nerve fibres and vessels within it. Outside: the duodenum and its lumen where the juice works (and the enterokinase that switches the enzymes on), the bile duct that shares the ampulla, the blood that brings glucose, amino acids and gut hormones and carries the hormones away (to the liver first), the gut's enteroendocrine cells, the brain and autonomic nerves, and the tissues that answer insulin and glucagon (liver, muscle, fat).
nested levelAn organ of the vertebrate body that belongs to two organ systems at once: an accessory organ of the digestive system (sys:digestive-system) and a gland of the endocrine system (sys:endocrine-system); built from acini, ducts and islets.
scaleorganism

Measures (32) published science

adult pancreas massabout 80-120 (about 70 in the 7th decade) g
adult pancreas length12-15 (Gray's, per src:wp:pancreas); 15-20 (src:mihoc-2024-acute-pancreatitis) cm
exocrine share of the pancreas99 (endocrine 1) %
acinar share of the exocrine gland~90 %
islet share of pancreas volume1-2 (with 10-15% of its blood flow)
islets in an adult human pancreasabout 1 million (average diameter about 0.2 mm; up to 3,000 cells each) islets
islet blood flow5-6 (up to 15 times the exocrine tissue) mL/min per g islet
beta-cell share of human islet cellsabout 40-50 (rodents 60-80) %
human beta cells touching other endocrine cells71 %
beta cells each beta cell is electrically coupled to6-7 cells
alpha-cell share of islets in type 1 diabetes50-70 %
pancreatic juice per day1.5-3 (WP); 2~3 (Ishiguro) L/day
maximum bicarbonate in human pancreatic juice140-150 (mouse ~50, rat ~70) mM
bicarbonate plus chloride in pancreatic juice~160 (constant) mM
insulin pulse intervalabout 5 (earlier estimates about 15) min
insulin half-life in circulation4-8 (WP: ~4-6) min
insulin granule maturation time3 h
insulin per granule (human beta cell)about 1.7 amol
hepatic first-pass insulin extraction40-80 % of secreted insulin
portal-to-peripheral fall in insulin pulse amplitude5-fold ratio
insulin fall when glucose drops below 60 mg/dL80-90 % decrease
insulin after intravenous glucose relative to oral glucoseone third ratio
share of insulin after an oral glucose load attributed to gut factorsabout half (Perley and Kipnis) fraction
insulin chain length (human)51 amino acids (5808 Da) residues
start of human pancreas development27-29 (mouse E8.5) days post conception
endocrine cells differentiate from ductsweeks 8-10; islets form from the 3rd month; zymogen granules after 20 weeks weeks of gestation
insulin and glucagon detectable in fetal circulation4th-5th month month of development
acute pancreatitis mortality3 (mild oedematous) to 20 (necrotising) %
gallstone share of acute pancreatitis (Western countries)20-70 % of cases
pancreatic adenocarcinoma survival25 at one year, 5 at five years % alive
people living with diabetes, 2024828 million (200 million in 1990); type 2 is 85-90% of cases people
cystic fibrosis in Caucasian newborns1 in 2,500-3,500 (Japan ~3 per million) births

Open contentions (7) open contention

Where sources or readings disagree. Both stay on the map.

Partners and parts published science

Built from / builds (13)

Sits inside / holds (3)

Trades with (valence) (14)

expressed by (11)

floor filled by (15)

Kinds (5)

wired (1)

Notes published science

Layers

The ways it takes in its world, where they meet, and how it acts back, each from L1 (where it meets the world) up.

the boardroom (shared floors)

  1. L5: Control of both glands at once: the islets' paracrine network and the acini and ducts combine what blood glucose and amino acids, gut hormones (incretins, secretin, CCK), vagal and sympathetic nerves and local signals say; the brain's counter-regulation overrides the islets when glucose falls
  2. L6: The two outputs set to the body's state: hormones into the portal blood (insulin in pulses on a basal rate, glucagon, somatostatin, pancreatic polypeptide) and pancreatic juice into the duodenum (zymogens, lipase, amylase, 1.5-3 L a day of bicarbonate-rich fluid)
  3. L7: The pancreas's part in the whole body: blood glucose held in a narrow range with the liver (fuel stored after meals, released between them) and each meal's proteins, fats and starch digested in the duodenum

the pancreas as anatomists and physiologists describe it: what the blood, gut hormones and nerves bring, how the islets and acini read it, and what goes out as hormones and pancreatic juice (reader's view)

  1. L1: What reaches it: arterial blood from the coeliac and superior mesenteric arteries carrying glucose, amino acids, fatty acids and gut hormones; fibres from the vagus and the coeliac and superior mesenteric plexuses
  2. L2: Sensors and receptors: GLUT2, glucokinase and KATP channels in beta (and alpha) cells; GPCRs for incretins, adrenaline and acetylcholine on islet cells; secretin receptors and CFTR on duct cells
  3. L3: Stimulus-secretion coupling: metabolism raises ATP/ADP, KATP closes, the cell depolarises and Ca2+ triggers granule release; cAMP opens CFTR in duct cells; acinar cells release zymogen granules
  4. L4: Working units: about a million islets (alpha, beta, delta, PP, epsilon cells, beta cells coupled to six or seven beta neighbours, glomerulus-like fenestrated capillaries) and the acini with their duct tree from intercalated to main duct
  5. L5: Control: paracrine wiring in the islet, vagal and sympathetic nerves, incretins, secretin and CCK, and the brain's counter-regulation when glucose falls
  6. L6: The two outputs: hormones into the portal blood (insulin pulses on a basal rate, glucagon) and 1.5-3 L a day of pancreatic juice (zymogens and bicarbonate up to 140-150 mM) into the duodenum
  7. L7: The whole-body part: blood glucose held in a narrow range with the liver, fuel stored after meals and released between them, and meals digested

way in: Amino acids in the blood

  1. L1: Amino acids from digested protein and from the liver's balance of them, carried in blood
  2. L2: Read by alpha and beta cells
  3. L3: Stimulate insulin and glucagon secretion; in mice, lasting amino-acid excess drives alpha cells to multiply
  4. L4: The liver-alpha-cell axis: glucagon drives hepatic amino acid breakdown, amino acids feed back on alpha cells

way in: Blood glucose

  1. L1: Glucose in arterial blood reaching the islet's fenestrated capillaries (5-6 mL/min per g of islet)
  2. L2: GLUT2 lets glucose into the beta cell; glucokinase, the low-affinity hexokinase, phosphorylates it in proportion to its level
  3. L3: ATP/ADP rises, KATP channels close, the membrane depolarises, Ca2+ enters and granules fuse (first phase from docked granules, second from the reserve pool); in alpha cells the same closure shrinks action potentials and cuts glucagon
  4. L4: The islet: beta cells coupled to six or seven beta neighbours; pulses synchronised within and between islets

way in: Damage signals from the gland's own cells

  1. L1: Damage-associated molecular patterns (DAMPs) released from injured acinar cells
  2. L2: Read by resident and incoming immune cells; neutrophils recruited
  3. L3: Proinflammatory cytokines; neutrophil extracellular traps that activate trypsinogen further
  4. L4: Local inflammation of the gland (oedematous or necrotising)

way in: Duodenal acid, carried as secretin (with VIP)

  1. L1: Secretin released from duodenal S cells when stomach acid enters; carried in blood
  2. L2: Secretin receptors on duct and centroacinar cells; isolated ducts respond to secretin
  3. L3: cAMP opens CFTR; SLC26A6 Cl-HCO3 exchange near the acini, CFTR's own HCO3 conductance further down
  4. L4: The duct tree: fluid volume and bicarbonate rise together, chloride falls, sum near 160 mM

way in: Fat and protein in the duodenum, carried as cholecystokinin

  1. L1: Cholecystokinin from I cells of the duodenum and jejunum, mostly after long-chain fatty acids
  2. L2: Reception at the acinar gland (receptor not named in the sources read)
  3. L3: Enzyme secretion raised; CCK increases the effects of secretin
  4. L4: Acini release zymogen granules into the intercalated ducts

way in: Gut hormones from a meal (incretins GIP and GLP-1)

  1. L1: GIP from duodenal K cells after glucose or fat; GLP-1 from ileal and colonic L cells; carried in blood
  2. L2: G protein-coupled receptors on islet cells (GIP and GLP-1 receptors)
  3. L3: Glucose-dependent amplification of insulin release
  4. L4: The islet's postprandial insulin: about half of insulin after oral glucose is attributed to gut factors

way in: Pressure in the ducts

  1. L1: Pressure of the juice inside the ducts (raised when outflow is blocked)
  2. L2: 5-HT-immunoreactive enterochromaffin cells scattered in the duct epithelium may sense it
  3. L3: Released 5-HT may inhibit fluid secretion (5-HT3 receptor antagonist changes in vivo secretion in guinea pigs)
  4. L4: Duct fluid output held down while pressure is high

way in: Sympathetic (splanchnic) input and circulating catecholamines

  1. L1: Noradrenaline from splanchnic sympathetic fibres; adrenaline from the adrenal medulla in blood
  2. L2: Beta-2 adrenergic receptors (stimulate) and alpha adrenergic receptors (inhibit) on islet cells
  3. L3: In alpha cells adrenaline raises cAMP and releases ER calcium to drive glucagon
  4. L4: Net effect on the islets: less insulin, more glucagon

way in: The islet's own hormones read by neighbouring cells

  1. L1: Insulin, glucagon, somatostatin (and in humans, acetylcholine from alpha cells) released into the islet's spaces and capillaries
  2. L2: Receptors on neighbours: somatostatin receptors on alpha and beta cells, glucagon receptors on beta cells
  3. L3: Somatostatin inhibits alpha and beta cells; glucagon enhances glucose-induced insulin; insulin damps alpha cells, possibly via delta cells
  4. L4: Blood runs past the mantle cells before the core in islets with a core (as stated for human islets by Mihoc; human islets mix cell types, Cabrera)

way in: Trypsin and mast-cell tryptase read through PAR2

  1. L1: Active trypsin (and mast cell tryptase) in duct and tissue fluid
  2. L2: PAR2 on acinar cells, duct cells, stellate cells, nerve endings and endothelium

way in: Vagal (parasympathetic) input, including the cephalic phase

  1. L1: Acetylcholine from vagal fibres reaching islets and acini; started by the brain, including at the sight, smell and taste of food
  2. L2: M3 muscarinic receptors on beta cells
  3. L3: Insulin release raised; enzyme and fluid secretion raised in the exocrine gland
  4. L4: Proposed: cholinergic input synchronises islets

way out: Bicarbonate-rich fluid into the duodenum

  1. L1: Juice up to 140-150 mM bicarbonate neutralises gastric acid in the duodenum
  2. L3: SLC26A6 exchange and CFTR conductance across the duct cell's apical membrane; water through aquaporins
  3. L6: Fluid and bicarbonate output raised by secretin and VIP, lowered by 5-HT, substance P, vasopressin and ATP

way out: Digestive enzymes into the duodenum

  1. L1: In the duodenal lumen enterokinase activates trypsinogen; trypsin activates the rest; proteins, fats and starch broken down
  2. L2: Down the main duct to the ampulla of Vater with the common bile duct, through the sphincter of Oddi
  3. L4: Acinar cells release zymogen granules into intercalated ducts; centroacinar cells' fluid flushes them along
  4. L6: Enzyme output raised by CCK, vagal acetylcholine and secretin

way out: Glucagon into the portal blood

  1. L1: To the liver: glycogenolysis and gluconeogenesis; amino acid breakdown
  2. L3: Alpha-cell action potentials and P/Q-type Ca2+ channels drive exocytosis at low glucose
  3. L6: Released fast when glucose falls (the first-line defence), and by adrenaline

way out: Inflammation and pain sent out when the gland is injured

  1. L1: Systemic inflammatory response, organ failure or shock in severe cases; central abdominal pain radiating to the back
  2. L3: Proinflammatory mediators released; pain carried centrally
  3. L5: Injury inflammation in the gland

way out: Insulin (with amylin) into the portal blood

  1. L1: Into the portal vein; the liver takes 40-80% on first pass; half-life in circulation 4-8 min
  2. L3: Ca2+-triggered exocytosis of granules; each human granule holds about 1.7 amol of insulin
  3. L6: Release in pulses on a basal rate; first phase from docked granules, second phase from the reserve pool

way out: Somatostatin and pancreatic polypeptide

  1. L1: Somatostatin acts mostly on neighbouring alpha and beta cells and inhibits PP release
  2. L6: Delta cells release somatostatin at high glucose; PP cells release pancreatic polypeptide

Sources (18) published science

Human digestive system (Wikipedia, via Wikimedia Enterprise)
Pancreas (encyclopedia; Wikimedia Enterprise snapshot 2026-11-01)
Mihoc T, Latcu SC, Secasan CC, et al. Pancreatic morphology, immunology, and the pathogenesis of acute pancreatitis. Biomedicines 2024;12(11):2627. doi:10.3390/biomedicines12112627 (PMC11591934; CC BY) (behind its links)
Ishiguro H, Yamamoto A, Nakakuki M, et al. Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium. Nagoya J Med Sci 2012;74(1-2):1-18 (PMC4831246; CC BY-NC-ND) (behind its links)
Pancreatic islets (encyclopedia; Wikimedia Enterprise snapshot 2026-11-01) (behind its links)
Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. PNAS 2006;103(7):2334-2339. doi:10.1073/pnas.0510790103 (PMC1413730; abstract read) (behind its links)
Steiner DJ, Kim A, Miller K, Hara M. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets 2010;2(3):135-145. doi:10.4161/isl.2.3.11815 (PMC2908252; full text via NCBI E-utilities) (behind its links)
Laurenti MC, Matveyenko A, Vella A. Measurement of pulsatile insulin secretion: rationale and methodology. Metabolites 2021;11(7):409. doi:10.3390/metabo11070409 (PMC8305896) (behind its links)
Wolfe MM, Boylan MO, Chin WW. Glucose-dependent insulinotropic polypeptide in incretin physiology: role in health and disease. Endocr Rev 2025. doi:10.1210/endrev/bnaf006 (PMC12259236) (behind its links)
Insulin (encyclopedia; Wikimedia Enterprise snapshot 2026-11-01) (behind its links)
Ma Z, Zhang X, Zhong W, et al. Deciphering early human pancreas development at the single-cell level. Nat Commun 2023;14:5354. doi:10.1038/s41467-023-40893-8 (PMC10475098) (behind its links)
Diabetes (encyclopedia; Wikimedia Enterprise snapshot 2026-11-01) (behind its links)
Rorsman P, Ashcroft FM. Pancreatic β-cell electrical activity and insulin secretion: of mice and men. Physiol Rev 2018;98(1):117-214. doi:10.1152/physrev.00008.2017 (PMC5866358; full text not open to automated XML, abstract read) (behind its links)
Gao R, Acreman S, Ma J, et al. α-cell electrophysiology and the regulation of glucagon secretion. J Endocrinol 2023. doi:10.1530/joe-22-0295 (PMC10326640) (behind its links)
Hayashi Y, Seino Y. Regulation of amino acid metabolism and α-cell proliferation by glucagon. J Diabetes Investig 2018. doi:10.1111/jdi.12797 (PMC5934249) (behind its links)
Ogunnowo-Bada EO, Heeley N, Brochard L, Evans ML. Brain glucose sensing, glucokinase and neural control of metabolism and islet function. Diabetes Obes Metab 2014;16 Suppl 1:26-32. doi:10.1111/dom.12334 (PMC4405079) (behind its links)
Ikegami H, Babaya N, Noso S. β-Cell failure in diabetes: common susceptibility and mechanisms shared between type 1 and type 2 diabetes. J Diabetes Investig 2021. doi:10.1111/jdi.13576 (PMC8409822) (behind its links)
Qi W, Wang G, Wang L. A novel satiety sensor detects circulating glucose and suppresses food consumption via insulin-producing cells in Drosophila. Cell Res 2021. doi:10.1038/s41422-020-00449-7 (PMC8089096; CC BY) (behind its links)